743
Views
19
CrossRef citations to date
0
Altmetric
Review Article

An overview of treatment of overactive bladder syndrome in women

&
Pages 217-221 | Published online: 28 Feb 2012

References

  • Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U . 2002. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society. American Journal of Obstetrics and Gynecology 187:116–126.
  • Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD . 2006. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology 148:565–578.
  • Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C . 2010. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourology and Urodynamics 29:213–240.
  • Anger JT, Weinberg A, Suttorp MJ, Litwin MS, Shekelle PG. 2010. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature. Journal of Urology 183: 2258–2264.
  • Arya LA, Myers DL, Jackson ND. 2000. Dietary caffeine intake and the risk for detrusor instability: A case–control study. Obstetrics and Gynecology 96:85–89.
  • Bartoli S, Aguzzi G, Tarricone R. 2010. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology 75:491–500.
  • Brubaker L, Richter HE, Visco A, Mahajan S, Nygaard I, Braun TM . 2008. Refractory idiopathic urge urinary incontinence and botulinum A injection. Journal of Urology 180:217–222.
  • Bryant CM, Dowell CJ, Fairbrother G. 2002. Caffeine reduction education to improve urinary symptoms. British Journal of Nursing 11:560–565.
  • Bump RC, McClish DK. 1992. Cigarette smoking and urinary incontinence in women. American Journal of Obstetrics and Gynecology 167: 1213–1218.
  • Chancellor MB, Kianifard F, Beamer E, Mongay L, Ebinger U, Hicks G . 2008. A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder. International Journal of Clinical Practice 62:606–613.
  • Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. 2008. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and metaanalysis. European Urology 54:543–562.
  • Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM. 2009. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews (4):CD001405.
  • de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P . 2010. Pelvic organ prolapse and overactive bladder. Neurourology and Urodynamics 29:30–39.
  • Ellsworth PI, Brunton SA, Wein AJ, Rovner ES. 2009. Frequently asked questions in the evaluation and management of overactive bladder. Journal of Family Practice 58(10 Suppl):S1–S12.
  • Elser DM, Wyman JF, McClish DK, Robinson D, Fantl JA, Bump RC. 1999. The effect of bladder training, pelvic floor muscle training, or combination training on urodynamic parameters in women with urinary incontinence. Continence Program for Women Research Group. Neurourology and Urodynamics 18:427–436.
  • Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW. 2006. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstetrics and Gynecology 108:93–99.
  • Garnett S, Swithinbank L, Ellis-Jones J, Abrams P. 2009. The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women. BJU International 104:948–953.
  • Godec C, Cass AS, Ayala GF. 1975. Bladder inhibition with functional electrical stimulation. Urology 6:663–666.
  • Gray M. 2001. Caffeine and urinary continence. Journal of Wound, Ostomy, and Continence Nursing 28:66–69.
  • Hanson LA, Schulz JA, Flood CG, Cooley B, Tam F. 2006. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success. Urology 17:155–159.
  • Hashim H, Al Mousa R. 2009. Management of fluid intake in patients with overactive bladder. Current Urology Reports 10:428–433.
  • Herbison GP, Arnold EP. 2009. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database of Systematic Reviews (2):CD004202.
  • Hisayama T, Shinkai M, Takayanagi I, Toyoda T. 1988. Mechanism of action of nicotine in isolated urinary bladder of guinea-pig. British Journal of Pharmacology 95:465–472.
  • Hunskaar S. 2008. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourology and Urodynamics 27:749–757.
  • MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC . 2010. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. Journal of Urology 183: 234–240.
  • Mattiasson A, Blaakaer J, Hoye K, Wein AJ. 2003. Tolterodine Scandinavian Study G. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU International 91:54–60.
  • McClish DK, Fantl JA, Wyman JF, Pisani G, Bump RC. 1991. Bladder training in older women with urinary incontinence: relationship between outcome and changes in urodynamic observations. Obstetrics and Gynecology 77:281–286.
  • Michel MC, Schneider T, Krege S, Goepel M. 2002. Does gender or age affect the efficacy and safety of tolterodine? Journal of Urology 168:1027–1031.
  • Miedel A, Tegerstedt G, Morlin B, Hammarstrom M. 2008. A 5-year prospective follow-up study of vaginal surgery for pelvic organ prolapse. Obstetrics and Gynecology 19:1593–1601.
  • Milne JL. 2004. Behavioral therapies at the primary care level: the current state of knowledge. Journal of Wound, Ostomy, and Continence Nursing 31:367–378.
  • NICE. 2006. Urinary incontinence guideline CG40. London: National Institute of Clinical Excellence. Available at: http://www.nice.org.uk/nicemedia/pdf/CG40NICEguideline.
  • Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL . 2010. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. Journal of Urology 183:1438–1443.
  • Ridout AE, Yoong W. 2010. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy. Journal of Obstetrics and Gynaecology 30:111–114.
  • Rittenmeyer H. 2008. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system. Urologic Nursing 28:15–20.
  • Roxburgh C, Cook J, Dublin N. 2007. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews (4):003190.
  • Sahai A, Dowson C, Khan MS, Dasgupta P. 2009. Improvement in quality of life after Botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. BJU International 103:1509–1515.
  • Shafik A, Shafik IA. 2003. Overactive bladder inhibition in response to pelvic floor muscle exercises. World Journal of Urology 20:374–377.
  • Simpson LL. 2004. Identification of the major steps in botulinum toxin action. Annual Review of Pharmacology and Toxicology 44:167–193.
  • Starkman JS, Smith CP, Staskin DR. 2010. Surgical options for drug-refractory overactive bladder patients. Reviews in Urology 12:e97–e110.
  • Swithinbank L, Hashim H, Abrams P. 2005. The effect of fluid intake on urinary symptoms in women. Journal of Urology 174:187–189.
  • Tomlinson BU, Dougherty MC, Pendergast JF, Boyington AR, Coffman MA, Pickens SM. 1999. Dietary caffeine, fluid intake and urinary incontinence in older rural women. Reviews in Urology 10:22–28.
  • Tampakoudis P, Tantanassis T, Grimbizis G, Papaletsos M, Mantalenakis S. 1995. Cigarette smoking and urinary incontinence in women – a new calculative method of estimating the exposure to smoke. European Journal of Obstetrics, Gynecology and Reproductive Biology 63:27–30.
  • van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama a Nijholt AA, Siegel S, Jonas U . 2007. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. Journal of Urology 178:2029–2034.
  • Waetjen LE, Dwyer PL. 2006. Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients? European Journal of Obstetrics, Gynecology and Reproductive Biology 17: 541–545.
  • Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I. 2009. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. European Urology 55:783–791.
  • Wing RR, Creasman JM, West DS, Richter HE, Myers D, Burgio KL . 2010. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstetrics and Gynecology 116(2 Pt 1):284–292.
  • Wooldridge LS. 2009. Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic. Urologic Nursing 29:177–185.
  • Wyman JF, Burgio KL, Newman DK. 2009. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. International Journal of Clinical Practice 63:1177–1191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.